Additionally, we established that the risk of CKD in heterozygous carriers with the BBS2 rs773862084 CA/AA genotype or the MKS1 rs199910690 CT/TT genotype was not higher compared to non-carriers, regardless of the BMI level. The gene discussed is BBS2; the disease is chronic kidney disease.